Efficient management of patient data with award-winning solutions helps reduce workload

Intelerad provides of medical imaging software and services for the healthcare industry. Nearly 2,500 healthcare organisations around the world use Intelerad products to manage patient data, helping them reduce time and workload while improving patient outcomes. Intelerad’s award-winning enterprise imaging solutions have been recognised by KLAS, with Ambra Health ranked number one medical image exchange for eight consecutive years.  The company will be sharing technology solutions designed to drive workflow efficiencies, provider excellence and better patient care. Schedule to meet with our UK team at RSNA here.

Learn why our Enterprise Imaging Suite is provider-preferred.

Intelerad’s Enterprise Imaging solutions include best-in-class technology from Image Exchange, a scalable PACS solution, market-leading workflow orchestrator, and more. Leveraging the suite gives users the ability to manage images from all modalities from capture through storing, viewing, sharing, and analytics.

Intelerad at RSNA 23: See the big picture

Nov 14, 2023 at 2-2:45 pm ET via Zoom

“We are excited to share with you new feature updates that drive efficiency gains and elevate patient outcomes,” Intelerad says. “You have been curious about our product strategy and, understandably, you want to know more about how our various systems fit together to help support your Enterprise Imaging goals. We want to take this opportunity to share our unified vision with you.

“Join us for an exclusive look at the developments we will be showcasing at RSNA 2023, hosted by our product leadership team.”

Discover how Intelerad’s innovations are revolutionising healthcare imaging, visit stand 6104, north hall.

This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine.  Visit our dedicated RSNA conference page to find out more.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more